Subscription Center
A recently exposed case of the agency's handling of drugs that reached the market in spite of fraudulent studies is no anomaly. The agency's response mirrors how it handled an earlier instance of scientific misconduct at another contract research organization
The FDA in 2011 announced years' worth of studies from a major drug research lab were potentially worthless, but it has not pulled any of the compounds from the market nor identified them
An investigative report about the influence of drug company money on scientific research, which appears in the December 2012 issue, started with a database of publicly available information. Here is how the author pieced together the report
The pharmaceutical industry funnels money to prominent scientists who are doing research that affects its products--and nobody can stop it
There's no way that anyone could pinpoint which baby became the seven billionth person living on Earth. The uncertainties in measurement are simply too huge
See what we're tweeting about
DrJudyStone Anti-Psychiatry Prejudice? A response to Dr. Lieberman http://t.co/rVqLYs8CSg cc @rocza @BoraZ @sandraupson @drjlieberman @yobluemama2
Horganism Obama: "A perpetual war... will prove self-defeating, and alter our country in troubling ways."
BoraZ W00t!!! Look @tdelene what just arrived in the mail! http://t.co/cEcoJhEVOa
Deadline: Jul 30 2013
Reward: $100,000 USD
The Seeker desires a method for producing pseudoephedrine products in such a way that it will be extremely difficult for clandestine che
Deadline: Jun 29 2013
Reward: $7,000 USD
The Seeker for this Challenge desires proposals for chemical methods that could rapidly degrade a dilute aqueous solution
Powered By: 
YES! Send me a free issue of Scientific American with no obligation to continue the subscription. If I like it, I will be billed for the one-year subscription.
